Docetaxel for the Treatment of Hormone-Refractory Prostate Cancer

بواسطة Petrylak, Daniel P
منشور في 2003

Docetaxel for the Treatment of Hormone-Refractory Prostate Cancer

بواسطة Petrylak, Daniel P
منشور في 2003

The Treatment of Hormone-Refractory Prostate Cancer: Docetaxel and Beyond

بواسطة Petrylak, Daniel P
منشور في 2006

New Paradigms for Advanced Prostate Cancer

بواسطة Petrylak, Daniel P
منشور في 2007

New developments in the treatment of castration resistant prostate cancer

بواسطة Wadia, Roxanne, Petrylak, Daniel P
منشور في 2014

Immune Analysis of Radium-223 in Patients with Metastatic Prostate Cancer

بواسطة Kim, Joseph W., Shin, Min Sun, Kang, Youna, Kang, Insoo, Petrylak, Daniel P
الحاوية / القاعدة Clin Genitourin Cancer (2017)

Abiraterone acetate and prednisone in chemotherapy-naïve prostate cancer patients: rationale, evidence and clinical utility

بواسطة Crawford, E. David, Shore, Neal D., Petrylak, Daniel P., Higano, Celestia S., Ryan, Charles J.
الحاوية / القاعدة Ther Adv Med Oncol (2017)

Prostate Cancer Update: Advanced Disease

بواسطة Carducci, Michael A, Crawford, E. David, Higano, Celestia S, Mendoza-Valdes, Arturo, Petrylak, Daniel P, Schalken, Jack
منشور في 2003

Hormone-Refractory Prostate Cancer: New Horizons

بواسطة Petrylak, Daniel P, Abrahamsson, Per-Anders, Bartsch, Georg, Carducci, Michael A, Small, Eric J, Wilding, George
منشور في 2003

Androgen Deprivation and Other Treatments for Advanced Prostate Cancer

بواسطة Brawer, Michael K, Crawford, E David, Labrie, Fernand, Mendoza-Valdes, Arturo, Miller, Paul D, Petrylak, Daniel P
منشور في 2001

Therapeutic Strategies for Localized Prostate Cancer

بواسطة Lynch, John H, Batuello, Joseph T, Crawford, E David, Gomella, Leonard G, Kaufman, Joel, Petrylak, Daniel P, Joel, Andrew B
منشور في 2001

Long-term Clinical Outcomes of a Phase I Trial of Intravesical Docetaxel in the Management of Non–muscle-invasive Bladder Cancer Refractory to Standard Intravesical Therapy

بواسطة Laudano, Melissa A., Barlow, Lamont J., Murphy, Alana M., Petrylak, Daniel P., Desai, Manisha, Benson, Mitchell C., McKiernan, James M.
الحاوية / القاعدة Urology (2009)

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer

بواسطة Armstrong, Andrew J., Eisenberger, Mario A., Halabi, Susan, Oudard, Stephane, Nanus, David M., Petrylak, Daniel P., Sartor, A. Oliver, Scher, Howard I.
منشور في 2011

GEMCITABINE AND CISPLATIN IN UNRESECTABLE MALIGNANT MESOTHELIOMA OF THE PLEURA: A PHASE II STUDY OF THE SOUTHWEST ONCOLOGY GROUP (SWOG 9810)

بواسطة Kalmadi, Sujith R., Rankin, Cathryn, Kraut, Michael J., Jacobs, Andrew D., Petrylak, Daniel P., Adelstein, David J., Keohan, Mary Louise, Taub, Robert N., Borden, Ernest C.
منشور في 2007

Health-related quality of life in the randomized phase 3 study of ramucirumab plus docetaxel versus placebo plus docetaxel in platinum-refractory advanced urothelial carcinoma (RAN...

بواسطة Necchi, Andrea, Nishiyama, Hiroyuki, Matsubara, Nobuaki, Lee, Jae-Lyun, Petrylak, Daniel P., de Wit, Ronald, Drakaki, Alexandra, Liepa, Astra M., Mao, Huzhang, Bell-McGuinn, Katherine, Powles, Thomas
الحاوية / القاعدة BMC Urol (2020)

A Double Blind Randomized Crossover Study of Oral Thalidomide versus Placebo in Patients with Stage D0 Androgen Dependent Prostate Cancer Following Limited Hormonal Ablation

بواسطة Figg, William D., Hussain, Maha H., Gulley, James L., Arlen, Philip M., Aragon-Ching, Jeanny B., Petrylak, Daniel P., Higano, Celestia S., Steinberg, Seth M., Sartor, Oliver, Dahut, William L.
منشور في 2009

Cooperative group trials – Southwest Oncology Group (SWOG) innovations in advanced prostate cancer

بواسطة Dorff, Tanya B., Tangen, Cathy M., Crawford, E. David, Petrylak, Daniel P., Higano, Celestia S., Raghavan, Derek, Quinn, David I., Vogelzang, Nicholas J., Thompson, Ian M., Hussain, Maha H.A.
منشور في 2009

SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Gué...

بواسطة Skinner, Eila C., Goldman, Bryan, Sakr, Wael A., Petrylak, Daniel P., Lenz, Heinz-Josef, Lee, Cheryl T., Wilson, Shandra S., Benson, Mitchell, Lerner, Seth P., Tangen, Cathy M., Thompson, Ian M.
منشور في 2013

Phase II Trial of Paclitaxel, Carboplatin and Gemcitabine in Patients with Locally Advanced Carcinoma of the Bladder

بواسطة Smith, David C., Mackler, Niklas J, Dunn, Rodney L., Hussain, Maha, Wood, David, Lee, Cheryl T., Sanda, Martin, Vaishampayan, Ulka, Petrylak, Daniel P., Quinn, David I., Beekman, Kathleen, Montie, James E.
منشور في 2008

KINETICS OF SERUM ANDROGEN NORMALIZATION AND FACTORS ASSOCIATED WITH TESTOSTERONE RESERVE AFTER LIMITED ANDROGEN-DEPRIVATION THERAPY IN NONMETASTATIC PROSTATE CANCER

بواسطة Gulley, James L., Aragon-Ching, Jeanny B., Steinberg, Seth M., Hussain, Maha H., Sartor, Oliver, Higano, Celestia S., Petrylak, Daniel P., Chatta, Gurkamal S., Arlen, Philip M., Figg, William D., Dahut, William L.
منشور في 2008